| Feb 27, 2026 |
Feb 27, 2026 |
Berger Mark Stanley
|
Chief Medical Officer |
Sell |
46.3
|
-7,168
|
-24.84%
|
✗
|
$14.3K |
| Feb 27, 2026 |
Feb 27, 2026 |
Confer Ryan M.
|
CEO |
Sell |
46.3
|
-9,330
|
-20.43%
|
✗
|
$18.7K |
| Dec 22, 2025 |
Dec 23, 2025 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
90.0
|
+9,000
|
5732.48%
|
✗
|
- |
| Dec 22, 2025 |
Dec 23, 2025 |
Berger Mark Stanley
|
Chief Medical Officer |
Neutral |
90.0
|
+28,500
|
7916.67%
|
✗
|
- |
| Dec 22, 2025 |
Dec 23, 2025 |
Confer Ryan M.
|
CEO |
Neutral |
90.0
|
+45,000
|
6807.87%
|
✗
|
- |
| Dec 22, 2025 |
Dec 23, 2025 |
LONGNECKER BRENT M
|
Director |
Neutral |
90.0
|
+9,000
|
5142.86%
|
✗
|
- |
| Dec 22, 2025 |
Dec 23, 2025 |
Wilson William R Jr.
|
Director |
Neutral |
90.0
|
+9,000
|
5732.48%
|
✗
|
- |
| Jun 30, 2025 |
Jul 1, 2025 |
Berger Mark Stanley
|
Chief Medical Officer |
Sell |
47.5
|
-4,500
|
-20.03%
|
✗
|
$1K |
| Jun 30, 2025 |
Jul 1, 2025 |
Confer Ryan M.
|
CEO |
Sell |
47.5
|
-5,775
|
-14.91%
|
✗
|
$1.3K |
| Feb 18, 2025 |
Feb 19, 2025 |
Berger Mark Stanley
|
Chief Medical Officer |
Sell |
47.5
|
-585
|
-2.54%
|
✗
|
$239.9 |
| Feb 18, 2025 |
Feb 19, 2025 |
Confer Ryan M.
|
CEO |
Sell |
47.5
|
-395
|
-1.01%
|
✗
|
$162 |
| Dec 5, 2024 |
Dec 6, 2024 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
90.0
|
+4,750
|
153.47%
|
✗
|
- |
| Dec 5, 2024 |
Dec 6, 2024 |
Wilson William R Jr.
|
Director |
Neutral |
90.0
|
+4,750
|
153.47%
|
✗
|
- |
| Dec 5, 2024 |
Dec 6, 2024 |
LONGNECKER BRENT M
|
Director |
Neutral |
90.0
|
+4,750
|
119.65%
|
✗
|
- |
| Dec 5, 2024 |
Dec 6, 2024 |
Confer Ryan M.
|
CEO |
Neutral |
90.0
|
+29,375
|
300.88%
|
✗
|
- |
| Dec 5, 2024 |
Dec 6, 2024 |
Berger Mark Stanley
|
Chief Medical Officer |
Neutral |
90.0
|
+18,250
|
379.73%
|
✗
|
- |
| Feb 18, 2024 |
Feb 21, 2024 |
Berger Mark Stanley
|
Chief Medical Officer |
Sell |
47.5
|
-1,319
|
-21.53%
|
✗
|
$5.8K |
| Feb 18, 2024 |
Feb 21, 2024 |
Varner John Rodney
|
CEO |
Sell |
46.3
|
-2,642
|
-8.95%
|
✗
|
$11.6K |
| Feb 18, 2024 |
Feb 21, 2024 |
Confer Ryan M.
|
CFO |
Sell |
47.5
|
-1,126
|
-10.34%
|
✗
|
$5K |
| Jun 27, 2023 |
Jun 29, 2023 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
90.0
|
+123,795
|
100.00%
|
✗
|
- |
| Jun 27, 2023 |
Jun 29, 2023 |
LONGNECKER BRENT M
|
Director |
Neutral |
90.0
|
+123,795
|
353.70%
|
✗
|
- |
| Jun 27, 2023 |
Jun 29, 2023 |
Wilson William R Jr.
|
Director |
Neutral |
90.0
|
+123,795
|
100.00%
|
✗
|
- |
| Apr 21, 2023 |
Apr 24, 2023 |
Varner John Rodney
|
CEO |
Buy |
78.8
|
+19,000
|
1.64%
|
✗
|
$20K |
| Apr 21, 2023 |
Apr 24, 2023 |
VACZY CATHERINE M
|
EVP GC Chief Strategy Officer |
Buy |
86.3
|
+20,000
|
8.16%
|
✗
|
$21.5K |
| Feb 18, 2023 |
Feb 22, 2023 |
VACZY CATHERINE M
|
EVP GC Chief Strategy Officer |
Neutral |
90.0
|
+245,000
|
100.00%
|
✗
|
- |
| Feb 18, 2023 |
Feb 22, 2023 |
Berger Mark Stanley
|
Chief Medical Officer |
Neutral |
90.0
|
+245,000
|
100.00%
|
✗
|
- |
| Feb 18, 2023 |
Feb 22, 2023 |
Kumar Hermant
|
Chief Mfgr & Tech Officer |
Neutral |
90.0
|
+200,000
|
100.00%
|
✗
|
- |
| Feb 18, 2023 |
Feb 22, 2023 |
Confer Ryan M.
|
CFO |
Neutral |
90.0
|
+245,000
|
128.61%
|
✗
|
- |
| Feb 18, 2023 |
Feb 22, 2023 |
Varner John Rodney
|
CEO |
Neutral |
90.0
|
+625,000
|
116.49%
|
✗
|
- |
| Jul 28, 2022 |
Aug 1, 2022 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 29, 2022 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 27, 2022 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 27, 2022 |
LONGNECKER BRENT M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 27, 2022 |
Wilson William R Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2022 |
Jun 27, 2022 |
Kumar Hermant
|
Chief Mfgr & Tech Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2021 |
Feb 14, 2022 |
Varner John Rodney
|
CEO |
Neutral |
27.5
|
-1,614,152
|
-74.71%
|
✗
|
- |
| Feb 4, 2022 |
Feb 8, 2022 |
VACZY CATHERINE M
|
EVP GC Chief Strategy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2022 |
Feb 8, 2022 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2022 |
Feb 8, 2022 |
Varner John Rodney
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2022 |
Feb 8, 2022 |
Berger Mark Stanley
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 4, 2022 |
Feb 8, 2022 |
Kumar Hermant
|
Chief Mfgr & Tech Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 27, 2021 |
Sep 28, 2021 |
Kumar Hermant
|
Chief Mfgr & Tech Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 27, 2021 |
Sep 28, 2021 |
Berger Mark Stanley
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 28, 2021 |
Kumar Hermant
|
Chief Mfgr & Tech Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 28, 2021 |
Berger Mark Stanley
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2021 |
Jun 25, 2021 |
Wilson William R Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2021 |
Jun 25, 2021 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 24, 2021 |
Jun 25, 2021 |
LONGNECKER BRENT M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 5, 2021 |
Apr 7, 2021 |
LONGNECKER BRENT M
|
Director |
Buy |
95.0
|
+15,000
|
75.00%
|
✗
|
$62.3K |
|
Apr 7, 2021 |
LONGNECKER BRENT M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 19, 2021 |
Mar 23, 2021 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 19, 2021 |
Mar 23, 2021 |
VACZY CATHERINE M
|
EVP GC Chief Strategy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 19, 2021 |
Mar 23, 2021 |
Varner John Rodney
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 19, 2021 |
Mar 23, 2021 |
Redman Michael Thomas
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 21, 2020 |
Aug 25, 2020 |
Varner John Rodney
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 21, 2020 |
Aug 25, 2020 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2020 |
Jul 28, 2020 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2020 |
Jul 28, 2020 |
LONGNECKER BRENT M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 24, 2020 |
Jul 28, 2020 |
Wilson William R Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 31, 2020 |
LONGNECKER BRENT M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 31, 2020 |
Wilson William R Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 31, 2020 |
Wilson William R Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 30, 2019 |
Mar 20, 2020 |
Friedman David E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 30, 2019 |
Mar 20, 2020 |
Pearson Robert W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 20, 2020 |
Moreno Toscano Jose Antonio
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 20, 2020 |
Wilson William R Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 16, 2020 |
VACZY CATHERINE M
|
EVP & Chief Strategy Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 16, 2020 |
Redman Michael Thomas
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 30, 2019 |
Jan 2, 2020 |
Friedman David E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 30, 2019 |
Jan 2, 2020 |
Pearson Robert W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 5, 2019 |
Sep 9, 2019 |
Varner John Rodney
|
CEO |
Buy |
55.0
|
+1,800
|
0.08%
|
✗
|
$1.6K |
|
Feb 21, 2019 |
BONFIGLIO JOHN N
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 5, 2018 |
Feb 14, 2019 |
ROTH JACK A
|
10% Owner |
Neutral |
27.5
|
-250,000
|
-14.60%
|
✗
|
- |
| Nov 2, 2018 |
Feb 5, 2019 |
Friedman David E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2018 |
Feb 5, 2019 |
Varner John Rodney
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2018 |
Feb 5, 2019 |
Pearson Robert W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 25, 2019 |
Jan 29, 2019 |
Varner John Rodney
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 25, 2019 |
Jan 29, 2019 |
Pham Julien L
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 25, 2019 |
Jan 29, 2019 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2018 |
Nov 6, 2018 |
Genprex, Inc.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2018 |
Nov 6, 2018 |
Genprex, Inc.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2018 |
Nov 6, 2018 |
Genprex, Inc.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 27, 2018 |
Oct 1, 2018 |
Ly Viet-An Hoan
|
10% Owner |
Neutral |
27.5
|
-1,160,982
|
-96.99%
|
✗
|
- |
| Jul 30, 2018 |
Aug 2, 2018 |
Pham Julien L
|
COO |
Buy |
90.0
|
+500
|
100.00%
|
✗
|
$1.7K |
| Jul 27, 2018 |
Jul 31, 2018 |
Ly Viet-An Hoan
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2018 |
May 25, 2018 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2018 |
May 25, 2018 |
Pham Julien L
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 29, 2018 |
Apr 5, 2018 |
Varner John Rodney
|
CEO |
Buy |
65.0
|
+10,000
|
0.47%
|
✗
|
$50K |
| Mar 29, 2018 |
Apr 5, 2018 |
ROTH JACK A
|
10% Owner |
Buy |
82.5
|
+40,000
|
1.70%
|
✗
|
$200K |
| Mar 29, 2018 |
Apr 5, 2018 |
Nance Christy M.
|
10% Owner |
Buy |
85.0
|
+50,000
|
1.69%
|
✗
|
$250K |
|
Mar 29, 2018 |
Varner John Rodney
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
ROTH JACK A
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
Pham Julien L
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
Pearson Robert W.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
Nance Christy M.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
Ly Viet-An Hoan
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
Confer Ryan M.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 29, 2018 |
Friedman David E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |